title: [The use of monoclonal antibodies that recognize the neural cell adhesion molecule (NCAM) in the diagnosis of bone marrow localization of small cell lung cancer].
abstract: We have used immunocytochemistry to identify tumor cells in bone-marrow aspirates of 40 untreated patients with small cell lung cancer and we compared the results with conventional histomorphology. The monoclonal antibodies (MAbs) used were NCC-LU-243 and NCC-LU-246 (both cluster 1). For each MAb 76 slides were evaluated. Sixty bone-marrow biopsies were also obtained from these patients. The positivity rate between the 2 MAbs was not statistically different (46% for NCC-LU-246 and 43% for NCC-LU-243). Bone-marrow biopsies detected tumor localization in 8/60 specimens (13%), significantly less than immunocytochemistry with anti-NCAM MAbs (p = 0.003). Moreover, bone-marrow aspirates were positive for cluster 1 antigen in 6/16 patients with limited disease at diagnosis. The results confirm that NCC-LU-243 and NCC-LU-246 have equivalent ability to identify bone-marrow involvement; immunocytochemistry appears to be better suited for this purpose than conventional bone-marrow biopsy; a non-negligible proportion of patients with "limited disease" might be understaged; the clinical value of detecting bone marrow involvement by immunocytochemistry is still unclear.
authors.affiliation: Cattedra e Divisione di Oncologia Medica, Università di Verona.
authors.forename: F
authors.initials: F
authors.lastname: Pasini
authors.forename: G
authors.initials: G
authors.lastname: Pelosi
authors.forename: A
authors.initials: A
authors.lastname: Santo
authors.forename: M
authors.initials: M
authors.lastname: Zaninelli
authors.forename: R
authors.initials: R
authors.lastname: Mostacci
authors.forename: A
authors.initials: A
authors.lastname: Masotti
authors.forename: P
authors.initials: P
authors.lastname: Spagnolli
authors.forename: E
authors.initials: E
authors.lastname: Recaldin
authors.forename: G L
authors.initials: GL
authors.lastname: Cetto
mesh_terms: D000911:Antibodies, Monoclonal; D000954:Antigens, Surface / Q000032:analysis* / Q000276:immunology; D001706:Biopsy; D001853:Bone Marrow / Q000737:chemistry / Q000473:pathology*; D001856:Bone Marrow Examination / Q000379:methods; D001859:Bone Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000556:secondary*; D018288:Carcinoma, Small Cell / Q000737:chemistry / Q000473:pathology* / Q000556:secondary*; D015816:Cell Adhesion Molecules, Neuronal / Q000032:analysis* / Q000276:immunology; D006801:Humans; D039841:Leukocyte L1 Antigen Complex; D008175:Lung Neoplasms / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D015816:Cell Adhesion Molecules, Neuronal; D039841:Leukocyte L1 Antigen Complex
vernacular_title: L'uso di anticorpi monoclonali che riconoscono la neural cell adhesion molecule (NCAM) nella diagnosi delle localizzazioni midollari di microcitoma polmonare.